SOURCE: Medistem Laboratories

September 12, 2007 08:10 ET

Medistem Laboratories to Present at Wall Street Analyst Forum on September 20th

SCOTTSDALE, AZ--(Marketwire - September 12, 2007) - Medistem Laboratories (OTCBB: MDSM) announced today that Thomas Ichim, Chief of Scientific Development, and Steve Rivers, Chief Financial Officer, will present an overview of the Company at the 18th Annual Wall Street Analyst Forum on Thursday, September 20, 2007 at the Princeton Club in New York. Mr. Ichim and Mr. Rivers are scheduled to present at 3:20 pm eastern time (ET).

The presentation will also be available via webcast for thirty days. Interested parties can access the webcast at http://www.wsw.com/webcast/wsaf4/mdsm.ob.

About Medistem Laboratories, Inc.

Medistem Laboratories is a biotechnology company that discovers, develops, and commercializes adult stem cell products that address serious medical conditions. While drug discovery and development is its primary focus, Medistem has compiled a body of proprietary technologies it outlicenses to commercial entities in markets where stem cell administration is permissible. Due to its licensee relationships and collaborative efforts with respected institutions, Medistem believes it is well positioned to be a leading developer of adult stem cell products.

Contact Information